Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 11
2004 14
2005 13
2006 12
2007 12
2008 17
2009 17
2010 22
2011 26
2012 24
2013 34
2014 24
2015 31
2016 36
2017 46
2018 43
2019 38
2020 45
2021 41
2022 32
2023 25
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

506 results

Results by year

Filters applied: . Clear all
Page 1
Screening for liver fibrosis: lessons from colorectal and lung cancer screening.
Thiele M, Kamath PS, Graupera I, Castells A, de Koning HJ, Serra-Burriel M, Lammert F, Ginès P. Thiele M, et al. Among authors: lammert f. Nat Rev Gastroenterol Hepatol. 2024 Mar 13. doi: 10.1038/s41575-024-00907-2. Online ahead of print. Nat Rev Gastroenterol Hepatol. 2024. PMID: 38480849 Review.
Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis.
Salzmann RJS, Krötz C, Mocan T, Mocan LP, Grapa C, Rottmann S, Reichelt R, Keller CM, Langhans B, Schünemann F, Pohl A, Böhler T, Bersiner K, Krawczyk M, Milkiewicz P, Sparchez Z, Lammert F, Gehlert S, Gonzalez-Carmona MA, Willms A, Strassburg CP, Kornek MT, Dold L, Lukacs-Kornek V. Salzmann RJS, et al. Among authors: lammert f. Hepatol Commun. 2024 Feb 14;8(3):e0380. doi: 10.1097/HC9.0000000000000380. eCollection 2024 Mar 1. Hepatol Commun. 2024. PMID: 38358371 Free PMC article.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Corrigendum to 'A mixed-methods study to define Textbook Outcome for the treatment of patients with uncomplicated symptomatic gallstone disease with hospital variation analyses in Dutch trial data' [Volume 25, Issue 9, September 2023, Pages 1000-1010].
Thunnissen FM, Comes DJ, Latenstein CSS, Stommel MWJ, van Laarhoven CJHM, Drenth JPH, Lantinga MA, Atsma F, de Reuver PR; Invited International Collaborators. Thunnissen FM, et al. HPB (Oxford). 2024 Feb;26(2):321. doi: 10.1016/j.hpb.2023.11.006. Epub 2023 Nov 18. HPB (Oxford). 2024. PMID: 37996300 Free article. No abstract available.
Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study.
Pal SC, Castillo-Castañeda SM, Díaz-Orozco LE, Ramírez-Mejía MM, Dorantes-Heredia R, Alonso-Morales R, Eslam M, Lammert F, Méndez-Sánchez N. Pal SC, et al. Among authors: lammert f. Genes (Basel). 2023 Oct 13;14(10):1935. doi: 10.3390/genes14101935. Genes (Basel). 2023. PMID: 37895284 Free PMC article.
506 results